Wikidata

(Q64609802)

English

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

clinical trial

In more languages

Statements

short name
PREDICTRA (English)
0 references
title
A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA) (English)
0 references
medical condition
arthritis
0 references
inflammation
0 references
country
Australia
0 references
Austria
0 references
Canada
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Italy
0 references
Netherlands
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
main subject
arthritis
0 references
start time
15 December 2014
0 references
end time
8 August 2018
0 references
number of participants
149
0 references
minimum age
18 year
0 references
maximum age
99 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64609802&oldid=1857782086"